Your Article Summary
See Latest ArticlesMechanisms of avoidance of host immunity by Neisseria meningitidis and its effect on vaccine development
The Lancet Infectious Diseases, 06/24/09
Lo H et al. - Neisseria meningitidis remains an important cause of severe sepsis and meningitis worldwide. To date, available vaccines only protect individuals against subsets of meningococcal strains. However, two promising vaccines are currently being assessed in clinical trials and appear to offer good prospects for an effective means of protecting individuals against endemic serogroup B disease, which has proven to be a major challenge in vaccine research.
Related Articles
Absence of Neisseria meningitidis Serogroup C-Specific Antibodies during the First Year of Life in The Netherlands: an Age Group at Risk
Clinical and Vaccine Immunology, 10/06/09
Relevance Score: 85%
Prevalence and antimicrobial resistance pattern of bacterial meningitis in Egypt
Annals of Clinical Microbiology and Antimicrobials, 10/13/09
Relevance Score: 80%
Invasive meningococcal disease in Malta: an epidemiological overview, 1994–2007
Journal of Medical Microbiology, 10/21/09
Relevance Score: 77%
Today in CNS Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Rabies viral encephalitis – clinical determinants in diagnosis with special reference to paralytic form
Journal of Neurology, Neurosurgery, and Psychiatry , 12/18/09
Reactivation and centripetal spread of herpes simplex virus complicating acoustic neuroma resection
Surgical Neurology, 12/18/09
Tick-borne encephalitis in children: an update on epidemiology and diagnosis
Expert Review of Anti-infective Therapy, 12/18/09